abrdn Life Sciences Investors
HQL
57 hedge funds and large institutions have $64.6M invested in abrdn Life Sciences Investors in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 11 closing their positions.
117% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 12
7% more capital invested
Capital invested by funds: $60.2M → $64.6M (+$4.32M)
0.19% less ownership
Funds ownership: 14.56% → 14.37% (-0.19%)
3% less funds holding
Funds holding: 59 → 57 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$583K |
| 2 |
Cohen & Steers
New York
|
+$496K |
| 3 |
Invesco
Atlanta,
Georgia
|
+$387K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$336K |
| 5 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.18M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.13M |
| 3 |
DA
Doliver Advisors
Houston,
Texas
|
-$632K |
| 4 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$456K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$362K |
HQL Hedge Fund Activity: Q3 2018 in Review
57 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2018, worth a combined $64.6M — up 7.2% from $60.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of HQL and 9 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 26 added.
The largest buyer was Wells Fargo, adding an estimated $583K. The largest seller was Morgan Stanley, cutting an estimated $1.18M.
- 57 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2018, down from 59 in Q2 2018.
- Funds reported $64.6M of abrdn Life Sciences Investors stock for Q3 2018, up 7.2% quarter-over-quarter.
- 9 funds opened new abrdn Life Sciences Investors positions in Q3 2018 and 11 closed out, a net change of -2 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2018 was Wells Fargo, an estimated $583K added.
- The largest abrdn Life Sciences Investors seller in Q3 2018 was Morgan Stanley, an estimated $1.18M sold.
Based on aggregated 13F filings for Q3 2018.